Display options
Cite
Briars L, Todd T. A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. J Pediatr Pharmacol Ther. 2016;21(3):192-206doi: 10.5863/1551-6776-21.3.192.
Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 21(3), 192-206. https://doi.org/10.5863/1551-6776-21.3.192
Briars, Leslie, and Todd, Timothy. "A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 21,3 (2016): 192-206. doi: https://doi.org/10.5863/1551-6776-21.3.192
Briars L, Todd T. A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. J Pediatr Pharmacol Ther. 2016 May-Jun;21(3):192-206. doi: 10.5863/1551-6776-21.3.192. PMID: 27453697; PMCID: PMC4956327.
Copy Download .nbib Format: NLM
Share it on

J Pediatr Pharmacol Ther. 2016 May-Jun;21(3):192-206. doi: 10.5863/1551-6776-21.3.192.

A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Leslie Briars, Timothy Todd

Affiliations

  1. Department of Pharmacy Practice, The University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
  2. Department of Pharmacy Practice, Midwestern University, Downers Grove, Illinois.

PMID: 27453697 PMCID: PMC4956327 DOI: 10.5863/1551-6776-21.3.192

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common psychological diagnosis in children. This disorder impacts children and adolescents in all areas of life, including academic performance, extracurricular activities, and social interactions. ADHD can continue into adulthood where unemployment and substance abuse has been described. Although behavioral therapy is recommended for all patients with ADHD, medication management typically is initiated soon after diagnosis. Psychostimulants remain the primary medication of choice. This review focuses on the clinical use of psychostimulant medication in children and adolescents. The pharmacodynamic and pharmacokinetic differences between the newest long-acting formulations as well as commonly encountered adverse drug reactions, with suggested management strategies, will be highlighted. Non-stimulant therapy with atomoxetine or alpha2-adrenergic agonists is also reviewed. These agents may be warranted for patients who cannot tolerate psychostimulant therapy or have a comorbid condition. Finally, the 8-year multimodal treatment study results are also discussed.

Keywords: adolescent; alpha2-agonist; amphetamine; atomoxetine; attention deficit disorder with hyperactivity; central nervous system stimulants; child; clonidine; methylphenidate; pediatric

References

  1. J Child Psychol Psychiatry. 2013 Mar;54(3):227-46 - PubMed
  2. Pediatrics. 2011 Nov;128(5):1007-22 - PubMed
  3. Drugs. 2006;66(8):1117-26 - PubMed
  4. Pediatrics. 1999 Apr;103(4):e43 - PubMed
  5. J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63 - PubMed
  6. CNS Drugs. 2009;23 Suppl 1:21-31 - PubMed
  7. J Child Adolesc Psychopharmacol. 1990 Spring;1(1):87-102 - PubMed
  8. Expert Opin Pharmacother. 2010 Oct;11(15):2549-56 - PubMed
  9. Pharmacotherapy. 2009 Jun;29(6):656-79 - PubMed
  10. Pediatrics. 2004 Apr;113(4):762-9 - PubMed
  11. J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):484-500 - PubMed
  12. J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):171-9 - PubMed
  13. J Child Adolesc Psychopharmacol. 2011 Feb;21(1):21-32 - PubMed
  14. Expert Opin Pharmacother. 2012 Oct;13(15):2207-13 - PubMed
  15. Biol Psychiatry. 2005 Jun 1;57(11):1313-23 - PubMed
  16. Postgrad Med. 2010 Sep;122(5):78-87 - PubMed
  17. Child Adolesc Psychiatry Ment Health. 2007 Sep 27;1(1):10 - PubMed
  18. J Clin Child Adolesc Psychol. 2008 Jan;37(1):184-214 - PubMed
  19. Pediatrics. 2014 Oct;134(4):e935-44 - PubMed
  20. Biol Psychiatry. 2005 Jun 1;57(11):1336-46 - PubMed
  21. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I102-16 - PubMed
  22. Expert Rev Neurother. 2007 Feb;7(2):195-201 - PubMed
  23. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):989-1002 - PubMed
  24. Drugs. 2010;70(1):15-40 - PubMed
  25. Paediatr Drugs. 2009;11(3):203-26 - PubMed
  26. Pediatrics. 2008 Aug;122(2):451-3 - PubMed
  27. J Child Adolesc Psychopharmacol. 2014 Aug;24(6):302-10 - PubMed
  28. J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921 - PubMed
  29. Psychopharmacology (Berl). 2007 Oct;194(2):197-209 - PubMed
  30. Pediatr Clin North Am. 2011 Feb;58(1):99-120, xi - PubMed
  31. Pharmacotherapy. 2003 Oct;23(10):1281-99 - PubMed
  32. J Am Acad Child Adolesc Psychiatry. 2010 Mar;49(3):217-28.e1-3 - PubMed
  33. CNS Drugs. 2013 Jan;27(1):15-30 - PubMed
  34. Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):25 - PubMed
  35. Am J Psychiatry. 2007 Jun;164(6):942-8 - PubMed
  36. Neurotherapeutics. 2012 Jul;9(3):490-9 - PubMed
  37. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):689-700 - PubMed
  38. Curr Psychiatry Rep. 2008 Oct;10(5):424-31 - PubMed
  39. Arch Pediatr Adolesc Med. 2007 Sep;161(9):857-64 - PubMed
  40. Pediatrics. 2004 Mar;113(3 Pt 1):e206-16 - PubMed

Publication Types